Search research articles
Contact Us
Filters
Showing results (141-150 of 161) with videos related to
Page
of 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 13, 2011
Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials
Vincenzo Valentini, Ruud G P M van Stiphout, Guido Lammering, et al.
British Journal of Cancer
|
September 16, 2015
Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort
Alix Portal, Simon Pernot, David Tougeron, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 27, 2015
Selection of appropriate end-points (pCR vs 2yDFS) for tailoring treatments with prediction models in locally advanced rectal cancer
Vincenzo Valentini, Ruud G P M van Stiphout, Guido Lammering, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 24, 2009
Treatment of advanced hepatocellular carcinoma with long-acting octreotide: a phase III multicentre, randomised, double blind placebo-controlled study
Jean-Claude Barbare, Olivier Bouché, Franck Bonnetain, et al.
Oncotarget
|
October 24, 2018
Surrogate endpoints in advanced sarcoma trials: a meta-analysis
Marion Savina, Saskia Litière, Antoine Italiano, et al.
International Journal of Oncology
|
February 6, 2019
Efficacy of aflibercept with FOLFOX and maintenance with fluoropyrimidine as first‑line therapy for metastatic colorectal cancer: GERCOR VELVET phase II study
Benoist Chibaudel, Jean-Baptiste Bachet, Thierry André, et al.
The Lancet. Oncology
|
October 18, 2015
Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial
Christophe Tournigand, Benoist Chibaudel, Benoit Samson, et al.
Bulletin Du Cancer
|
April 4, 2012
[PAIR-gynaecology: multi/interdisciplinary for gynecologic cancer research. Problems needed to be resolved]
Isabelle Ray-Coquard, Franck Chauvin, Eric Leblanc, et al.
Cancer Medicine
|
June 3, 2016
Prognostic value of health-related quality of life for death risk stratification in patients with unresectable glioblastoma
Brice Paquette, Dewi Vernerey, Bruno Chauffert, et al.
Cancer
|
December 13, 2017
Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes
Fabio Efficace, Francesco Cottone, Gregory Abel, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 161) with videos related to
Sort By:
Page
of 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 13, 2011
Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials
Vincenzo Valentini, Ruud G P M van Stiphout, Guido Lammering, et al.
British Journal of Cancer
|
September 16, 2015
Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort
Alix Portal, Simon Pernot, David Tougeron, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 27, 2015
Selection of appropriate end-points (pCR vs 2yDFS) for tailoring treatments with prediction models in locally advanced rectal cancer
Vincenzo Valentini, Ruud G P M van Stiphout, Guido Lammering, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 24, 2009
Treatment of advanced hepatocellular carcinoma with long-acting octreotide: a phase III multicentre, randomised, double blind placebo-controlled study
Jean-Claude Barbare, Olivier Bouché, Franck Bonnetain, et al.
Oncotarget
|
October 24, 2018
Surrogate endpoints in advanced sarcoma trials: a meta-analysis
Marion Savina, Saskia Litière, Antoine Italiano, et al.
International Journal of Oncology
|
February 6, 2019
Efficacy of aflibercept with FOLFOX and maintenance with fluoropyrimidine as first‑line therapy for metastatic colorectal cancer: GERCOR VELVET phase II study
Benoist Chibaudel, Jean-Baptiste Bachet, Thierry André, et al.
The Lancet. Oncology
|
October 18, 2015
Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial
Christophe Tournigand, Benoist Chibaudel, Benoit Samson, et al.
Bulletin Du Cancer
|
April 4, 2012
[PAIR-gynaecology: multi/interdisciplinary for gynecologic cancer research. Problems needed to be resolved]
Isabelle Ray-Coquard, Franck Chauvin, Eric Leblanc, et al.
Cancer Medicine
|
June 3, 2016
Prognostic value of health-related quality of life for death risk stratification in patients with unresectable glioblastoma
Brice Paquette, Dewi Vernerey, Bruno Chauffert, et al.
Cancer
|
December 13, 2017
Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes
Fabio Efficace, Francesco Cottone, Gregory Abel, et al.
Page
of 17